Edmonton Metropolitan Region Webinar July 21, 2020 Program - - PowerPoint PPT Presentation
Pharmaceutical Innovation & Production Edmonton Metropolitan Region Webinar July 21, 2020 Program Introductions and Presentations Canada Trade Commissioner Service Sameena Qureshi, The Hague, Netherlands Michelle Gartland,
Webinar July 21, 2020
Introductions and Presentations
Question & Answer
Let us handle the introductions Laissez-nous faire les présentations
July 21, 2020
incentives in the industrialized world
industry, including contract research
manufacturing organizations (CMO)
https://www.investcanada.ca/industries/life-sciences
Research & Development Advantages
innovation from lab to market; joint investment opportunities in research allow for R&D result optimization. https://www.investcanada.ca/industries/life-sciences
the establishment and operation of pharmaceuticals facilities (Source: Competitive Alternatives Report of 2016 by KPMG).
clinical trials operations, offering significant cost savings over the US, according to the same report. A Low Cost Research and Manufacturing Base
million hold a degree from a STEM or health care program.
engineers, Canada’s Global Skills Strategy allows employers to bring in highly skilled talent from abroad in as little as two weeks.
with an extensive network of academic health institutions, research centres, 17 medical schools, and over 13,000 health researchers employed at dozens of health care organizations.
Skilled Labour Pool
market for pharmaceuticals sales
and logistics infrastructure which, according to the World Bank, is one of the world’s best. Logistics and Market Access Benefits
market, the largest drugs consumption market, and to Mexico’s own growing pharmaceuticals market.
v Luxembourg ratified CETA on May 6, 2020 v Guaranteed preferential access to the EU and North American markets; v Enhanced intellectual property rights provide greater protection for investments made in Canada’s pharmaceutical industry; v CETA provides a mechanism for Canada and the EU to mutually accept the results of each
v Greater access to government procurement markets: CETA’s government procurement provisions cover the procurement of pharmaceutical products as well as a broad range of services that may be of interest to the pharmaceutical sector, including technical testing and analysis services.
https://www.international.gc.ca/trade-commerce/trade-agreements-accords- commerciaux/agr-acc/ceta-aecg/business-entreprise/sectors-secteurs/PE-EPP.aspx?lang=eng
v Assistance in developing a business case for your next investment decision. v Strategic, sector-specific market intelligence. v Path-finding for key government contacts engaged in supporting investment in Canada. v Referrals to investment support professionals and private-sector industry associations. v Facilitation of site visits to support you in the identification of a strategic location. v Information and advice on how to set up a business in Canada, taxation, regulations and government programs.
Ask for a one-on-one consultation after the webinar
10
Trade Commissioner Service in the Netherlands and in Luxembourg
www.tradecommissioner.gc.ca
Trade Commissioner Service in the Netherlands
Sameena QURESHI Senior Trade Commissioner Embassy of Canada to the Kingdom of the Netherlands sameena.qureshi@international.gc.ca T: +31-70 311 1690 Melanie TER MEULEN Trade Commissioner Investment melanie.termeulen@international.gc.ca T+31-70 311 1692 Caroline BOLDUC Trade Commissioner Science and Technology caroline.bolduc@international.gc.ca T: +31-70 311 1653
Trade Commissioner Service in Luxembourg
Michelle GARTLAND Senior Trade Commissioner Embassy of Canada to the Grand Duchy of Luxembourg michelle.gartland@international.gc.ca T: +32 2 741 0622 Fabienne DE KIMPE Trade Commissioner Life Sciences fabienne.de-kimpe@international.gc.ca T: +32 2 741 0621
Trade & Investment Team
EDMONTON METROPOLITAN REGION —
The youngest communities in Canada and the top community for youth
130,000+ students enrolled in seven universities and colleges
The fastest-growing region in Canada, attracting investment, attention, and top talent from around the world
Alberta Health Services - largest integrated health system Re Research institutes
EDMONTON METROPOLITAN REGION —
Co Commercia ializ lizatio ion a n and nd I Inno nnovatio ion
HEALTH & LIFE SECTORS —
70% of Alberta’s life science companies are located in the region
development spending
the region’s GDP
Edmonton Int’l Ai Airport is the first airport in Canada to achieve certification from the Int’l Air Transport Association (IATA) for Center of Excellence for Independent Validators in Pharmaceutical Logistics (CE CEIV P Pha harma).
CANADA —
agreements to 51 countries
Rail, Road, Air, and Pipeline
direct link from Edmonton via Port of Prince Rupert
including 24-hour access for air transport
Professor, Dept of Biochemistry, UAlberta CAMSEED Drug Discovery Consortium Founder and co-Director, SMALP Network Founder and co-Director, DiscoveryLab
Funders:
UNIVERSITY OF ALBERTA & DISCOVERY LAB
NMR spectrum
>800 kinase inhibitors
leads in cell & mouse models
modes by NMR
Membrane proteins represent the majority of drug targets and can only be solubilized and analysed in native states using SMALP technology
translational modifications by methods including cryo-EM
Alternative Complex III, C Sun, Nature, 2018 Open and Super Open Glycine Receptor, J Yu et al. 2020 Asymmetric lipid bilayer
polymers, assays, drug discovery platforms
We are an industry centered not-for-profit institute focused on supporting and expanding the pharmaceutical industry in Alberta We work in a unique model focused on unlocking the potential of academic institutions to support the development and manufacture of life science products We have supported over 30 companies in the past 2 years from around the globe in all stages of drug development, from training and developing active pharmaceutical ingredient manufacturing to running bioanalytical studies to clinical trials and pk reporting
Manufacturing
Characterization
Thousands of new graduates annually from top ranked programs at research institutions such as the University of Alberta and polytechnics such as NAIT. Talent pool of tens of thousands of chemical engineers, chemists, technicians, and more. Expertise in the global top 15 for fields such as Engineering and Pharmacy and Pharmaceutical Sciences and Canada’s most hands-on undergraduate chemistry program. Decades of regional experience as a petrochemical powerhouse with supply chains, logistics, and support; one of the few airports in the world IATA pharmaceutical handling certification Location suitable for manufacturing with vast amounts of land all within 30 min of highly livable and affordable communities, low humidity year-round, stable access to inputs, low costs of doing business, proximity to North American markets, Asia,
A network of intermediate producers Existing infrastructure quickly leveraged to support scale-up Continuous flow chemistry and other innovations API production as well as finished dosage form
VP of Operations and General Manager
commercialization of innovative therapeutics in areas of unmet medical need that advance patient care
process and analytical methods, scale up, and supply of Active Pharmaceutical Ingredients under GMP
GILEAD ALBERTA ULC —
North America and Europe
institutions
International Airport – ease of receiving raw materials and shipping finished goods
GILEAD ALBERTA ULC —
Development, Analytical Chemistry, Production, Commercial API Process Optimization, Quality Assurance, Engineering/Maintenance and EH&S
secondary education
GILEAD ALBERTA ULC —
GILEAD ALBERTA ULC —
GILEAD ALBERTA ULC —
from 400 to 4000 L as well as ancillary filtration and drying equipment
Amanpreet Bhatti
Investment and Trade Edmonton Global
Health & Life Sciences AI & Tech Manufacturing Energy & Clean Tech Food & Agriculture
Talent Video